Liu Yingyu, Zhong Lijun, Sun Zhouyang, Feng Yuan, Ding Qianlu, Zhang Yujian
Division of Surveillance and Evaluation, Chinese Center for Health Education, Beijing, China.
Department of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun, China.
Matern Child Nutr. 2025 Apr;21(2):e13767. doi: 10.1111/mcn.13767. Epub 2024 Nov 28.
Long-chain n-3 polyunsaturated fatty acid (PUFA) consumption in maternal and infants has been positively associated with cognitive and visual development. Tails even meta-analysis showed mixed results. To evaluate the effects of maternal and infant n-3 PUFA supplementation on childhood psychomotor and cognitive development, PubMed, Embase, the Cochrane Library, PsycINFO and clinicaltrials.gov were searched. Randomized controlled trials were included to evaluate the effect on child cognitive and psychomotor outcomes of n-3 PUFA supplementation in mothers or infants (age ≤ 2 years). Findings were pooled with mean differences (MD) with 95% confidence intervals (95% CIs). Heterogeneity was explored using I and subgroup analyses, stratified for maternal (pregnancy and/or lactation) and infant (preterm infant and term infant). We identified 47 articles, with 14 trials on mothers and 33 on infants. Pooled results showed that infants' mental development index (MDI) increased with n-3 PUFA supplementation (MD = 2.91, 95% CI: 1.32-4.51, I = 65.1%). Subgroup analysis of MDI also demonstrated a benefit in preterm infants (MD = 4.16, 95% CI: 1.40-6.93, I = 49.5%) and term infants (MD = 2.28, 95% CI: 0.27-4.29, I = 70.1%). No significant association was found in subgroup analyses of supplementation to mothers during pregnancy or lactation period. Supplementation did not increase the psychomotor development index (PDI) in the mother or infant group. Language composite score increased for infants whose mothers accepted supplementation in pregnancy or breastfeeding (MD = 8.57, 95% CI: 5.09-12.04, I = 70.2%). The cognitive composite score did not improve in any subgroup. Intelligence Quotient (IQ) increased in the infants' group with n-3 PUFA supplementation (MD = 2.54, 95% CI: 0.45-4.63, I = 66.0%). Furthermore, IQ in term infants also improved (MD = 2.91, 95% CI: 0.24-5.57, I = 69.2%). The funnel plot and Egger's test confirmed no publication bias in any endpoints. Supplementation with n-3 PUFA during pregnancy or breastfeeding in mothers has increased language abilities. Furthermore, direct supplementation in term infants can improve intelligence in later childhood. However, insufficient evidence supports the claim that supplementation improves cognitive abilities.
母婴摄入长链n-3多不饱和脂肪酸(PUFA)与认知和视觉发育呈正相关。尾部偶数荟萃分析结果不一。为评估母婴补充n-3 PUFA对儿童心理运动和认知发育的影响,检索了PubMed、Embase、Cochrane图书馆、PsycINFO和clinicaltrials.gov。纳入随机对照试验以评估母亲或婴儿(年龄≤2岁)补充n-3 PUFA对儿童认知和心理运动结局的影响。结果合并为平均差(MD)及95%置信区间(95%CI)。采用I²和亚组分析探讨异质性,按母亲(孕期和/或哺乳期)和婴儿(早产儿和足月儿)分层。我们识别出47篇文章,其中14项针对母亲的试验和33项针对婴儿的试验。合并结果显示,补充n-3 PUFA可使婴儿的智力发育指数(MDI)升高(MD = 2.91,95%CI:1.32 - 4.51,I² = 65.1%)。MDI的亚组分析也显示对早产儿(MD = 4.16,95%CI:1.40 - 6.93,I² = 49.5%)和足月儿(MD = 2.28,95%CI:0.27 - 4.29,I² = 70.1%)有益。孕期或哺乳期母亲补充n-3 PUFA的亚组分析未发现显著关联。补充n-3 PUFA未增加母亲或婴儿组的心理运动发育指数(PDI)。母亲在孕期或哺乳期接受补充的婴儿,其语言综合评分升高(MD = 8.57,95%CI:5.09 - 12.04,I² = 70.2%)。任何亚组的认知综合评分均未改善。补充n-3 PUFA的婴儿组智商升高(MD = 2.54,95%CI:0.45 - 4.63,I² = 66.0%)。此外,足月儿的智商也有所提高(MD = 2.91,95%CI:0.24 - 5.57,I² = 69.2%)。漏斗图和Egger检验证实各终点均无发表偏倚。母亲在孕期或哺乳期补充n-3 PUFA可提高语言能力。此外,直接给足月儿补充n-3 PUFA可改善其儿童期后期的智力。然而,证据不足支持补充n-3 PUFA可提高认知能力这一说法。